George Clinical India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 12 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 71.50%
- Profit Growth 114.64%
- Ebitda 96.61%
- Net Worth 75.37%
- Total Assets 68.81%
About George Clinical India
George Clinical India Private Limited (GCIPL) is a leading Private Limited Foreign Company Incorporated In India incorporated in India on 04 October 2012 and has a history of 12 years and four months. Its registered office is in Bangalore, Karnataka.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Abby Abraham, Mamatha Jacob, and Mary Gunn serve as directors at the Company.
Company Details
- Location Bangalore, Karnataka
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U73100KA2012FTC080639
- Company No.
080639
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
04 Oct 2012
- Date of AGM
25 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at George Clinical India?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abby Abraham  | Director | 29-Jul-2020 | Current |
| Mamatha Jacob | Director | 30-Sep-2024 | Current |
| Mary Gunn | Director | 22-Oct-2024 | Current |
Financial Performance of George Clinical India.
George Clinical India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 71.5% increase. The company also saw a substantial improvement in profitability, with a 114.64% increase in profit. The company's net worth Soared by an impressive increase of 75.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of George Clinical India?
In 2023, George Clinical India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at George Clinical India?
George Clinical India has a workforce of 103 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of George Clinical India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped George Clinical India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
